RBC downgrades Caribou Biosciences to Sector Perform
RBC Capital cut Caribou Biosciences to Sector Perform and set a $1.00 price target, implying 11.9% downside versus the Oct. 6 close of $1.14.
Story updates
01:58:31 PM UTC
SquawkNews
Ratings actions from Benzinga: GMT) Caribou Biosciences Price Target Cut to $1.00/Share From $10.00 by RBC CapitalRatings actions from Benzinga